MyOme hosted a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines moderated by Akash Kumar MD, PhD, featuring cardiology experts Akl Fahed, MD, MPH, and Michael Levin, MD.

Public source

Publisher name

Public post

Join cardiology experts Akl Fahed, MD, MPH, and Michael Levin, MD, for a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines and what they mean for…

Log in to read the full post

Company

MyOme

Empowering individuals to take control of their health through actionable genomic insights.

Industry
Biotechnology Research
Location
Palo Alto, US
Company size
51–200 employees

About MyOme

Using whole genome sequencing and state-of-the-art bioinformatics, MyOme analyzes a single patient sample to produce comprehensive and clinically actionable reports that allow patients and their providers to make personalized lifestyle, prevention, and treatment choices.

See more

Latest activity

2 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.